Sutro Biopharma Income Statement (2017-2025) | STRO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 17.50M4.04M5.79M5.70M7.84M19.09M8.63M10.53M12.28M11.30M7.15M9.47M17.82M8.28M14.66M28.05M8.52M10.65M5.90M28.10M25.15M8.63M12.67M10.41M16.92M113.72M13.01M17.80M8.52M14.81M5.70M63.74M9.69M
Operating items
Research & Development 13.67M15.14M13.08M13.75M12.64M14.79M15.18M16.14M16.90M17.39M17.62M17.24M19.36M22.74M22.56M25.31M26.60M29.93M29.99M32.33M31.71M43.13M39.40M41.59M45.67M53.77M56.88M62.02M62.11M71.04M51.60M38.33M39.85M
Wages, Salaries and Other 28.40M28.27M28.94M22.30M8.51M3.86M17.89M
Selling, General & Administrative 4.89M4.07M4.41M4.04M5.35M7.57M7.71M8.07M8.12M8.70M8.71M8.64M9.08M10.38M11.11M12.54M16.59M15.76M15.04M15.14M14.64M14.72M15.51M15.00M15.27M16.80M12.72M12.37M14.33M9.03M13.27M10.34M8.74M
Restructuring Costs 4.25M13.01M7.31M
Other Operating Expenses 16.79M5.42M2.25M
Operating Expenses 18.56M19.21M17.50M17.79M17.99M22.36M22.89M24.21M25.01M26.09M26.33M25.89M28.44M33.12M33.67M37.85M43.19M45.69M45.03M47.48M46.36M57.85M54.91M56.59M60.94M70.57M69.60M74.39M76.44M80.07M85.91M67.09M58.15M
Operating Income -1.06M-15.17M-11.70M-12.09M-10.16M-3.27M-14.27M-13.69M-12.73M-14.78M-19.18M-16.42M-10.62M-24.84M-19.01M-9.80M-34.67M-35.04M-39.13M-19.38M-21.21M-49.22M-42.24M-46.18M-44.01M43.15M-56.59M-48.69M-67.92M-65.26M-68.51M-3.35M-48.46M
EBIT -1.06M-15.17M-11.70M-12.09M-10.16M-3.27M-14.27M-13.69M-12.73M-14.78M-19.18M-16.42M-10.62M-24.84M-19.01M-9.80M-34.67M-35.04M-39.13M-19.38M-21.21M-49.22M-42.24M-46.18M-44.01M43.15M-56.59M-48.69M-67.92M-65.26M-68.51M-3.35M-48.46M
Non-operating items
Interest & Investment Income 0.06M-0.88M0.04M0.04M0.40M1.13M1.18M1.12M0.96M0.81M0.64M0.38M0.29M-5.29M0.20M0.17M0.11M-3.62M-0.66M-0.59M-2.79M7.49M-2.99M-2.92M4.55M4.56M4.10M4.91M22.17M-0.90M3.19M2.52M2.01M
Other Non Operating Income -0.18M0.12M-0.07M1.07M
Non Operating Income -0.18M0.12M-0.07M1.07M-1.62M0.68M19.13M-4.83M-7.45M-8.17M-8.40M
Net income details
EBT -1.24M-16.43M-12.05M-11.54M-10.24M-1.49M-14.25M-13.79M-12.91M-14.79M-19.59M-18.99M-12.64M-27.89M-19.67M-6.15M-30.90M-38.12M-39.11M-23.51M-19.49M-34.59M-49.66M-38.37M-47.45M46.87M-58.21M-48.01M-48.79M-70.09M-65.33M-11.52M-56.86M
Tax Provisions 2.50M0.40M0.15M1.84M15.81M0.01M2.39M-0.02M
Profit After Tax -1.42M-15.34M-12.05M-11.54M-10.24M-1.49M-14.25M-13.79M-12.91M-14.79M-19.59M29.87M17.14M-59.54M-30.36M-6.15M-30.90M-38.12M-39.11M-26.01M-19.49M-34.59M-50.05M-38.52M-49.28M31.07M-58.21M-48.02M-48.79M-72.44M-75.97M-11.50M-56.86M
Equity Income 48.86M29.78M-37.14M-10.69M4.33M4.48M-2.57M0.56M-3.74M3.50M11.81M-6.99M8.32M0.69M7.89M3.68M4.81M
Income from Continuing Operations -1.24M-16.43M-12.05M-11.54M-10.24M-1.49M-14.25M-13.79M-12.91M-14.79M-19.59M-18.99M-12.64M-27.89M-19.67M-6.15M-30.90M-38.12M-39.11M-26.01M-19.49M-34.59M-50.05M-38.52M-49.28M31.06M-58.21M-48.02M-48.79M-72.48M-65.33M-11.50M-56.86M
Consolidated Net Income -1.24M-16.43M-12.05M-11.54M-10.24M-1.49M-14.25M-13.79M-12.91M-14.79M-19.59M-18.99M-12.64M-27.89M-19.67M-6.15M-30.90M-38.12M-39.11M-26.01M-19.49M-34.59M-50.05M-38.52M-49.28M31.06M-58.21M-48.02M-48.79M-72.48M-65.33M-11.50M-56.86M
Income towards Parent Company -1.24M-16.43M-12.05M-11.54M-10.24M-1.49M-14.25M-13.79M-12.91M-14.79M-19.59M-18.99M-12.64M-27.89M-19.67M-6.15M-30.90M-38.12M-39.11M-26.01M-19.49M-34.59M-50.05M-38.52M-49.28M31.06M-58.21M-48.02M-48.79M-72.48M-65.33M-11.50M-56.86M
Net Income towards Common Stockholders -1.24M-16.43M-12.05M-11.54M-10.24M-1.49M-14.25M-13.79M-12.91M-14.79M-19.59M-18.99M-12.64M-27.89M-19.67M-6.15M-30.90M-38.12M-39.11M-26.01M-19.49M-34.59M-50.05M-38.52M-49.28M31.06M-58.21M-48.02M-48.79M-72.48M-65.33M-11.50M-56.86M
Additional items
EPS (Basic) -3.14-36.67-25.75-24.17-21.26-0.26-0.62-0.60-0.56-0.64-0.841.000.46-0.86-0.66-0.13-0.67-0.83-0.84-0.55-0.37-0.61-0.85-0.64-0.810.52-0.95-0.59-0.59-0.94-0.79-0.14-0.67
EPS (Weighted Average and Diluted) -0.60-0.560.940.45-1.89-0.13-0.67-0.83-0.84-0.55-0.37-0.61-0.85-0.64-0.810.52-0.95-0.59-0.59-0.94-0.79-0.14-0.67
Shares Outstanding (Weighted Average) 0.45M0.45M0.47M0.48M0.48M5.76M22.87M22.93M22.95M22.96M23.20M32.57M45.91M46.12M46.16M46.12M46.50M46.96M52.35M50.74M58.72M60.34M60.60M60.16M61.46M81.22M82.04M76.83M83.11M84.58M84.87M
Shares Outstanding (Diluted Average) 32.57M46.12M46.16M46.12M46.50M46.96M52.35M50.74M58.72M60.34M60.60M60.16M61.46M81.22M82.04M76.83M83.11M84.58M84.87M
EBITDA -1.06M-15.17M-11.70M-12.09M-10.16M-3.27M-14.27M-13.69M-12.73M-14.78M-19.18M-16.42M-10.62M-24.84M-19.01M-9.80M-34.67M-35.04M-39.13M-19.38M-21.21M-49.22M-42.24M-46.18M-44.01M43.15M-56.59M-48.69M-67.92M-65.26M-68.51M-3.35M-48.46M
Interest Expenses 0.23M0.38M0.38M-0.51M0.48M-0.65M1.16M1.23M1.14M0.82M1.06M2.96M2.32M-2.25M0.86M0.85M0.82M0.61M0.66M0.59M2.79M
Shares Outstanding 0.47M0.47M0.48M0.49M22.85M22.93M22.93M23.09M23.10M23.23M35.88M37.98M45.75M46.10M46.14M46.26M46.33M46.93M48.67M54.63M57.50M60.16M60.47M60.90M61.01M62.46M81.86M82.40M82.53M84.35M84.72M85.10M
Tax Rate -10.63-0.80-0.39-3.8833.74-0.02-3.410.16